|royalty pharma stock||0.2||0.1||861||86|
|royalty pharma stock price||1.33||0.6||6713||12|
|royalty pharma stock forecast||1.48||0.8||7734||1|
|royalty pharma stock price target||1.23||0.2||2310||96|
|royalty pharma stock symbol||1.55||0.8||9738||16|
|royalty pharma stock yahoo||1.38||0.2||6567||6|
|royalty pharma stock dividend||1.94||0.7||6139||85|
|royalty pharma stock price today||1.15||1||439||33|
|royalty pharma stock news||0.13||0.9||3641||72|
|royalty pharma stock quote||0.89||0.6||8351||89|
|royalty pharma stock ticker||1.26||0.3||5482||35|
|royalty pharma stock price stock price||1.22||0.3||2448||16|
|royalty pharma stock analysis||0.55||0.9||6196||2|
Royalty Pharma trades on the NASDAQ under the ticker symbol "RPRX." Who are Royalty Pharma's major shareholders? Royalty Pharma's stock is owned by many different institutional and retail investors.Can Royalty Pharma stock sustain its dividend?
The dividend payout ratio of Royalty Pharma is 42.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Royalty Pharma will have a dividend payout ratio of 21.12% next year. This indicates that Royalty Pharma will be able to sustain or increase its dividend.What are analysts' 1 year price targets for Royalty Pharma's stock?
3 analysts have issued 1 year price objectives for Royalty Pharma's stock. Their forecasts range from $46.00 to $51.00. On average, they expect Royalty Pharma's share price to reach $49.00 in the next twelve months. This suggests a possible upside of 25.7% from the stock's current price.What is the upside for Royalty Pharma (RPH) stock?
Their forecasts range from $46.00 to $51.00. On average, they expect Royalty Pharma's share price to reach $49.00 in the next twelve months. This suggests a possible upside of 25.7% from the stock's current price.